Product
Control arm MDR-TB regimen
2 clinical trials
8 indications
Indication
TuberculosisIndication
Multidrug-resistantIndication
InfectionIndication
BacteriaIndication
Pulmonary TuberculosisIndication
Mycobacterial InfectionsIndication
Bacterial InfectionsIndication
Gram-Positive Bacterial InfectionsClinical trial
Evaluating Newly Approved Drugs for Multidrug-resistant TB (endTB): A Clinical TrialStatus: Completed, Estimated PCD: 2023-06-01
Clinical trial
Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)Status: Active (not recruiting), Estimated PCD: 2024-09-01